Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, has gained widespread attention for its potential therapeutic benefits. While some studies highlight its effectiveness in treating anxiety, epilepsy, and sleep disorders, others raise concerns about its safety and regulation. Here’s a closer look at the latest research on CBD’s benefits and risks.
CBD for Anxiety and Sleep Disorders
One particular study examined CBD’s effects on anxiety and sleep disturbances. Researchers followed 72 adults, with most receiving a daily dose of 25 mg of CBD. The results were promising: 79.2% of participants reported reduced anxiety after the first month, while 66.7% experienced improved sleep quality. However, sleep improvements fluctuated over time, indicating that more research is needed to determine long-term effectiveness.
CBD for Epilepsy, Pain, and Schizophrenia
A broader review in Current Addiction Reports explored CBD’s efficacy across multiple conditions. The FDA-approved drug Epidiolex® has shown strong evidence for treating seizures in rare epilepsy disorders. However, research on CBD’s effects on anxiety, pain, and schizophrenia remains inconclusive. Some studies suggest that CBD has anti-inflammatory properties that may help with pain management, but further clinical trials are needed to confirm these benefits.
Potential Risks: Liver Health and Safety Concerns
Despite its potential, CBD is not without risks. A case report published in Mayo Clinic Proceedings documented a 56-year-old woman who developed acute liver injury after using a CBD product. She experienced symptoms like jaundice and elevated liver enzymes, which resolved after discontinuing CBD. This highlights the need for caution, especially for individuals with pre-existing liver conditions or those taking multiple medications.
The Need for Regulation and Further Research
While CBD holds promise as a natural remedy for various conditions, its safety and long-term effects remain unclear. The lack of regulation means that product quality and purity can vary significantly. As interest in CBD grows, more rigorous studies and better oversight will be essential to ensure both efficacy and consumer safety.
Read the article here: https://www.sciencedirect.com/science/article/pii/S0025619619300072
